Role of the histone deacetylase complex in acute promyelocytic leukaemia
- PMID: 9486654
- DOI: 10.1038/35895
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Abstract
Non-liganded retinoic acid receptors (RARs) repress transcription of target genes by recruiting the histone deacetylase complex through a class of silencing mediators termed SMRT or N-CoR. Mutant forms of RARalpha, created by chromosomal translocations with either the PML (for promyelocytic leukaemia) or the PLZF (for promyelocytic leukaemia zinc finger) locus, are oncogenic and result in human acute promyelocytic leukaemia (APL). PML-RARalpha APL patients achieve complete remission following treatments with pharmacological doses of retinoic acids (RA); in contrast, PLZF-RARalpha patients respond very poorly, if at all. Here we report that the association of these two chimaeric receptors with the histone deacetylase (HDAC) complex helps to determine both the development of APL and the ability of patients to respond to retinoids. Consistent with these observations, inhibitors of histone deacetylase dramatically potentiate retinoid-induced differentiation of RA-sensitive, and restore retinoid responses of RA-resistant, APL cell lines. Our findings suggest that oncogenic RARs mediate leukaemogenesis through aberrant chromatin acetylation, and that pharmacological manipulation of nuclear receptor co-factors may be a useful approach in the treatment of human disease.
Similar articles
-
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.Nature. 1998 Feb 19;391(6669):815-8. doi: 10.1038/35901. Nature. 1998. PMID: 9486655
-
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.Nat Genet. 1998 Feb;18(2):126-35. doi: 10.1038/ng0298-126. Nat Genet. 1998. PMID: 9462740
-
Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.Blood. 1998 Apr 15;91(8):2634-42. Blood. 1998. PMID: 9531570
-
[Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].Bull Cancer. 1998 Apr;85(4):301-3. Bull Cancer. 1998. PMID: 9752292 Review. French.
-
Transcriptional regulation in acute promyelocytic leukemia.Oncogene. 2001 Oct 29;20(49):7204-15. doi: 10.1038/sj.onc.1204853. Oncogene. 2001. PMID: 11704848 Review.
Cited by
-
The recognition of N-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line.PLoS One. 2011;6(11):e27892. doi: 10.1371/journal.pone.0027892. Epub 2011 Nov 23. PLoS One. 2011. PMID: 22132163 Free PMC article.
-
Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.Int J Clin Exp Pathol. 2015 Mar 1;8(3):2746-54. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045780 Free PMC article.
-
Recent insights into Histone Acetyltransferase-1: biological function and involvement in pathogenesis.Epigenetics. 2021 Aug;16(8):838-850. doi: 10.1080/15592294.2020.1827723. Epub 2020 Oct 4. Epigenetics. 2021. PMID: 33016232 Free PMC article. Review.
-
Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells.Oncogene. 2005 Mar 31;24(14):2398-409. doi: 10.1038/sj.onc.1208466. Oncogene. 2005. PMID: 15735724
-
Cloning and characterization of a novel human histone deacetylase, HDAC8.Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):199-205. Biochem J. 2000. PMID: 10926844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
